1. Home
  2. Analysis
  3. Furosemide
  4. Tibsovo

Furosemide and Tibsovo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Tibsovo (ivosidenib). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Tibsovo. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Tibsovo?

Tibsovo has active ingredients of ivosidenib. eHealthMe is studying from 1,420 Tibsovo users. Check the latest studies of Tibsovo.

On Jul, 12, 2026

19 people who take Furosemide and Tibsovo together, and have interactions are studied.

Furosemide and Tibsovo drug interactions.

What are the common drug interactions of Furosemide and Tibsovo, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)

male:

n/a

What are the common drug interactions of Furosemide and Tibsovo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 57.89%
  2. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 4 people, 21.05%
  3. Nausea (feeling of having an urge to vomit): 1 person, 5.26%
  4. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.26%
  5. Kaposi's Sarcoma (a tumour caused by human herpes virus): 1 person, 5.26%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.26%
  7. High Blood Pressure: 1 person, 5.26%
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 5.26%
  9. Breast Cancer Female: 1 person, 5.26%
  10. Brain Natriuretic Peptide Increased: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Tibsovo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Furosemide and Tibsovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tibsovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tibsovo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on furosemide and ivosidenib (the active ingredients of Furosemide and Tibsovo, respectively), and Furosemide and Tibsovo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.